Shares of Novo Nordisk A/S (NYSE:NVO) Sees Large Inflow of Net Money Flow

Novo Nordisk A/S (NYSE:NVO) traded negative at $54.8. On an intraday basis, the price dropped -0.56 points or -1.01%. The composite uptick value was $6.55 million while the combined downtick value was $4.89. The net money flow was $1.66 million while the up/down ratio was not very comforting at 1.34. The shares on a weekly note has seen a change in share price of -3.16%.According to the trading data, the shares saw a block trade with $1.83 million in upticks and $0 million in downticks. The up/down ratio for the block was calculated to be 0. The net money flow for the block trade was 1.83.


Institutional Investors own 7.48% of Novo Nordisk A/S shares.

Novo Nordisk A/S (NYSE:NVO) stock ended Monday session in the red zone in a volatile trading. The stock closed down 0.64 points or 1.16% at $54.72 with 1,042,428 shares getting traded. Post opening the session at $54.21, the shares hit an intraday low of $54.2 and an intraday high of $55.45 and the price was in this range throughout the day. The company has a market cap of $142,272 million and the number of outstanding shares have been calculated to be 2,600,000,000 shares. The 52-week high of Novo Nordisk A/S (NYSE:NVO) is $60.34 and the 52-week low is $46.17.

Novo Nordisk A/S is a healthcare company. The Company is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. It has a range of diabetes product portfolio, including a portfolio of modern insulins as well as a human once-daily GLP-1 analog. It operates in two segments: diabetes care and biopharmaceuticals. The Companys diabetes care segment covers insulins, GLP-1, other protein-related products (such as glucagon, protein-related delivery systems and needles), oral anti-diabetic drugs and obesity. Its biopharmaceuticals segment covers the therapy areas of haemophilia care, growth hormone therapy and hormone replacement therapy. The primary production facilities owned by the Company are located at a number of sites in Denmark, and internationally in the United States, France, China and Brazil.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.